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In 1998, the Society of Adolescent Health and Medicine (SAHM) advocated for national coverage rates 
of 90% or greater for measles, mumps, and rubella; hepatitis B; tetanus; and varicella vaccines among 
adolescents aged 13 years and older and endorsed the importance of state school entry requirements for 
vaccination among the sixth and seventh graders [1]. Data are clear that state-mandated school 
immunization re-quirements have significantly contributed to improving the rates of vaccination coverage 
among adolescents [2]. Exemp-tions to school immunization requirements continue to be a political 
football in many state legislatures across the United States. Parental concerns about vaccine safety have 
been responsible for as many as half of nonmedical exemptions to required mandated immunization and 
likely contribute to increased efforts to expand exemption efforts [2,3]. However, recent data have 
demonstrated that all the legislative efforts to expand exemptions have failed, and the majority of bills 
designed to restrict the types of allowed exemptions have been successful [3]. Unfortunately, mandates 
did not help achieve Healthy People 2010 adolescent vaccination benchmarks, and mandates alone will 
not be the only effective strategy for meeting the benchmarks set for 2020 objectives. Thus, alterative 
solutions and strategies are required. 
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In 2006, SAHM released a position paper espousing an “adolescent vaccine platform” recommended by 
multiple orga-nizations that linked vaccination to the three distinct annual visits during early, middle, and 
late adolescence [4]. Despite this logical and intuitive approach, the strategy has not been effec-tive in 
reaching all adolescent age groups. This has been particularly discouraging for those of us who have 
actively worked for the last two decades in an effort to increase the awareness and importance of 
adolescent preventive health services and immunizations. 
 
Improving immunization rates for all recommended adoles-cent vaccines is a complex effort and will 
require more than one solution or strategy. A qualitative study identified six barriers to achieving high 
rates of adolescent vaccination: concerns of the general public; concerns of health care professionals; 
vaccine delivery issues; minor consent; vaccine cost and financing; and lack of coordination in the timing 
of vaccine recommendations, supply, and financing [5]. Each of these barriers will require a substantial 
investment of resources to achieve effective and pragmatic solutions. 
 
In 2010, Merck and Company, Inc. released a request for proposals to develop, implement, and evaluate 
innovative public health demonstration projects to promote improved immuni-zation rates among 
adolescents. Given the wealth of immunization-related researchers that identify SAHM as their primary 
organization, the Society submitted an application which was funded in July 2011. 
 
After developing the necessary infrastructure, that is, gov-erning and grant review committees, SAHM 
created a request for proposals with three primary objectives. Each potential application was to de.ne an 
effective strategy for increasing adolescent vaccination; promote racial, ethnic, and socioeco-nomic 
equality through vaccination; and disseminate this strategy such that it could be successfully replicated in 
other settings. Applicants were encouraged to use a public health practice approach, target a large number 
of adolescents, and include a strong evaluation component to ensure the validity of obtained results. In 
addition, any products or materials that developed and distributed with grant monies would be 
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disseminated to all interested parties. SAHM received more than 200 letters of intent that resulted in 82 
full proposals. In January 2012, SAHM funded 10 projects for a 24-month period. This supplement 
represents the culmination of this endeavor: 8 of 10 projects provide data about the public health 
strategies implemented and their effectiveness. It is our belief that these data, materials, and lessons 
learned can provide several missing pieces of a multifaceted approach to improve rates of adolescent 
immunization. 
 
One of the themes that emerged was that a “one size” fits all strategy model does not and will not 
universally improve rates of vaccination among adolescents or young adults. It is clear that we need to 
continue to work to increase awareness and knowledge of specific vaccines not just among parents and 
adolescents, but among health care professionals as well. In addition, we must avail ourselves of 
technology, especially programs that have been developed that can easily transfer from one platform to 
another to increase vaccination rates through automated data systems to track immunizations and 
reminder/ recall systems. Most importantly, consistent with best practices in public health, interventions 
must build communication and trust with targeted communities that ultimately develop culturally and 
linguistically competent messages and materials. Without this activity, technology or the intervention 
strategies will not be successful. Finally, we must work to increase access to the types of venues where 
vaccines are administered, and these should include alternative settings, such as mobile vans and school-
based health centers. To provide adolescent-friendly services, one must first find the adolescent patient. 
Many are not able to come to a defined medical home or other traditional primary care venue. 
 
The projects presented in this supplement provide a diverse set of strategies to mitigate barriers to 
adolescent vaccination, improve vaccination rates, and decrease disparities in vaccine-preventable 
diseases. It is our hope that these strategies will be disseminated broadly with the ultimate goal of 
improving health outcomes for adolescents and young adults. 
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